These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8009247)

  • 1. Pamidronate stimulates recruitment and decreases longevity of osteoclast nuclei in mice.
    Holt I; Marshall MJ; Davie MW
    Semin Arthritis Rheum; 1994 Feb; 23(4):263-4. PubMed ID: 8009247
    [No Abstract]   [Full Text] [Related]  

  • 2. Pamidronate decreases tumor-induced osteoclastogenesis in osteopetrotic mice.
    Clohisy DR; O' Keefe PF; Ramnaraine ML
    J Orthop Res; 2001 Jul; 19(4):554-8. PubMed ID: 11518261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast recruitment in mice is stimulated by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate.
    Marshall MJ; Holt I; Davie MW
    Calcif Tissue Int; 1993 Jan; 52(1):21-5. PubMed ID: 8453501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pamidronate prevents bone loss associated with carrageenan arthritis by reducing resorptive activity but not recruitment of osteoclasts.
    Moran EL; Fornasier TL; Bogoch TR
    J Orthop Res; 2000 Nov; 18(6):873-81. PubMed ID: 11192246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number.
    Piper K; Boyde A; Jones SJ
    Calcif Tissue Int; 1994 Jan; 54(1):56-61. PubMed ID: 8118755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate.
    Cheung MS; Glorieux FH; Rauch F
    J Bone Miner Res; 2009 Apr; 24(4):669-74. PubMed ID: 19063679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alteration of osteoclast morphology by diphosphonates in bone organ culture.
    Rowe EJ; Hausmann E
    Calcif Tissue Res; 1976 Apr; 20(1):53-60. PubMed ID: 1260493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony-stimulating factor-1 stimulates the fusion process in osteoclasts.
    Amano H; Yamada S; Felix R
    J Bone Miner Res; 1998 May; 13(5):846-53. PubMed ID: 9610749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study.
    Clarke NW; Holbrook IB; McClure J; George NJ
    Br J Cancer; 1991 Mar; 63(3):420-3. PubMed ID: 2003984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.
    Hussein O; Tiedemann K; Komarova SV
    Bone; 2011 Feb; 48(2):202-11. PubMed ID: 20849994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.
    Hughes DE; Wright KR; Uy HL; Sasaki A; Yoneda T; Roodman GD; Mundy GR; Boyce BF
    J Bone Miner Res; 1995 Oct; 10(10):1478-87. PubMed ID: 8686503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates can reduce osteoclastic bone resorption by two different mechanisms.
    Löwik CW; Boonekamp PM; van de Pluym G; van de Wee-Pals L; Bloys van Treslong-de Groot H; Bijvoet OL
    Adv Exp Med Biol; 1986; 208():275-81. PubMed ID: 2951984
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of tooth eruption in the rat by a bisphosphonate.
    Grier RL; Wise GE
    J Dent Res; 1998 Jan; 77(1):8-15. PubMed ID: 9437395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate on mouse osteoclasts.
    Marshall MJ; Wilson AS; Davie MW
    J Bone Miner Res; 1990 Sep; 5(9):955-62. PubMed ID: 2281826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
    Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
    J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ultrastructural study of the effects of bisphosphonate administration on osteoclastic bone resorption during relapse of experimentally moved rat molars.
    Kim TW; Yoshida Y; Yokoya K; Sasaki T
    Am J Orthod Dentofacial Orthop; 1999 Jun; 115(6):645-53. PubMed ID: 10358247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative ultrastructural analyses of rabbit osteoclasts. The effect of in vivo treatment with sodium salicylate.
    Kusakabe A; Francis MJ
    Nihon Seikeigeka Gakkai Zasshi; 1984 Mar; 58(3):349-60. PubMed ID: 6470542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro.
    Piper K; Boyde A; Jones SJ
    Anat Embryol (Berl); 1992 Sep; 186(4):291-9. PubMed ID: 1416078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro.
    Benford HL; McGowan NW; Helfrich MH; Nuttall ME; Rogers MJ
    Bone; 2001 May; 28(5):465-73. PubMed ID: 11344045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadmium stimulates osteoclast-like multinucleated cell formation in mouse bone marrow cell cultures.
    Miyahara T; Takata M; Miyata M; Nagai M; Sugure A; Kozuka H; Kuze S
    Bull Environ Contam Toxicol; 1991 Aug; 47(2):283-7. PubMed ID: 1717084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.